Accendra Health (ACH) EVP Galloway surrenders shares to cover restricted stock taxes

Rhea-AI Filing Summary

Accendra Health EVP and General Counsel Heath H. Galloway reported a routine tax-related share disposition. On May 18, 2026, 1,822 shares of Accendra Health common stock were surrendered at $2.91 per share to cover tax withholding tied to vesting of restricted stock.

These shares were delivered back to the company rather than sold in the open market. After this transaction, Galloway directly holds 166,306 shares of Accendra Health common stock, showing he retains a substantial equity stake following the tax withholding event.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Galloway Heath H

Role EVP,General Counsel & CorpSecy

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	1,822	$2.91	$5K

Holdings After Transaction: Common Stock — 166,306 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares surrendered for tax withholding: 1,822 shares Tax-withholding price: $2.91 per share Shares held after transaction: 166,306 shares

3 metrics

Shares surrendered for tax withholding 1,822 shares Restricted stock vesting on May 18, 2026

Tax-withholding price $2.91 per share Value used for surrendered shares

Shares held after transaction 166,306 shares Direct holdings after May 18, 2026 disposition

Key Terms

tax withholding obligations, restricted stock, surrendered to the Issuer, Form 4

4 terms

tax withholding obligations financial

"satisfy tax withholding obligations in connection with vesting of restricted stock"

restricted stock financial

"vesting of restricted stock granted to the Reporting Person"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

surrendered to the Issuer financial

"Represents shares surrendered to the Issuer to satisfy tax withholding obligations"

Form 4 regulatory

"INSIDER FILING DATA (Form 4): {"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Galloway Heath H

(Last) (First) (Middle)

ACCENDRA HEALTH INC.

4435 WATERFRONT DRIVE

(Street)

GLEN ALLEN VIRGINIA 23060

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ACCENDRA HEALTH INC/VA/ [ ACH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP,General Counsel & CorpSecy

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/18/2026		F		1,822(1)	D	$2.91	166,306	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person.

	Heath H. Galloway by Rosemarie France, POA	05/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Accendra Health (ACH) report for Heath H. Galloway?

Accendra Health reported that EVP and General Counsel Heath H. Galloway surrendered 1,822 shares of common stock at $2.91 per share. The shares were delivered back to the company to satisfy tax withholding obligations from vesting of restricted stock granted to him.

Was the Accendra Health (ACH) insider transaction an open-market sale?

No, the transaction was not an open-market sale. The 1,822 shares were surrendered to Accendra Health to cover tax withholding on vested restricted stock, a common administrative step, rather than sold to third-party buyers in the public market.

How many Accendra Health (ACH) shares does Heath H. Galloway hold after this filing?

Following the tax-withholding disposition, Heath H. Galloway directly holds 166,306 shares of Accendra Health common stock. This post-transaction figure, disclosed in the filing, indicates he maintains a significant remaining equity position in the company after the restricted stock vesting event.

What was the price used for the Accendra Health (ACH) tax-withholding shares?

The filing shows the 1,822 shares surrendered for tax withholding were valued at $2.91 per share. This price is used solely for the tax-related disposition calculation and does not necessarily represent a separate open-market trading price in this context.

Why did Accendra Health (ACH) shares get surrendered in this insider transaction?

The shares were surrendered to satisfy tax withholding obligations that arose when restricted stock granted to Heath H. Galloway vested. Instead of paying cash for taxes, he delivered 1,822 Accendra Health shares back to the company as permitted under the award terms.